Gyre Therapeutics
GYRE
#5622
Rank
NZ$1.66 B
Marketcap
$17.75
Share price
19.95%
Change (1 day)
-41.09%
Change (1 year)

EPS for Gyre Therapeutics (GYRE)

EPS in 2024 (TTM): $0.18

According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.43. In 2023 the company made an earnings per share (EPS) of -$2.43 a decrease over its 2022 EPS that were of $0.007523.

EPS history for Gyre Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)$0.18-107.22%
2023-$2.43-32451.8%
2022$0.007523-90.93%
2021$0.08290